From geriatric assessment to inflammation. A pilot, observational, study about frailty components in older patients with persistent atrial fibrillation
- PMID: 39639933
- PMCID: PMC11617777
- DOI: 10.1016/j.ijcha.2024.101558
From geriatric assessment to inflammation. A pilot, observational, study about frailty components in older patients with persistent atrial fibrillation
Abstract
Background: Atrial fibrillation (AF) is the most common arrhythmia diagnosed at an older age. AF is associated with frailty, a condition possibly justifying the higher rate of complications and mortality in aged individuals. This study was aimed at describing the characteristics correlated to frailty in older AF subjects.
Methods: After having excluded a < 3 months major surgery procedure, cancer or other conditions associated with activation of inflammation, and a life expectancy < 12 months, we consecutively enrolled patients ≥ 65 years with persistent AF. They underwent a Comprehensive Geriatric Assessment evaluation. In particular, Mini-Mental State Examination, 15-item Geriatric Depression Scale and Short-Physical Performance Battery (SPPB) described, respectively, cognitive profile, depressive symptoms and physical performance. A venous blood sample was collected to measure interleukin-6 (IL-6; marker of low-grade inflammation) and acylcarnitines, expression of mitochondrial dysfunction and abnormal energy production.
Results: Overall, 49 patients (mean age: 76 ± 6 years; women 30.6 %) were studied. Cluster analysis described two different patterns; the second (N = 18, 36.7 %), when compared to the first one (N = 31, 63.3 %), was characterized by a worse phenotype, identified by the simultaneous presence of lower body mass index, higher CHA2DS2-VASc score (index of clinical complexity), worse SPPB functional performance, and high IL-6 levels. Second cluster patients had a higher concentration of 13 of the 35 acylcarnitines evaluated and increased 5-year mortality. All these features can outline a frail condition.
Conclusions: Body size, clinical complexity, physical performance and low-grade inflammation seem to rapidly and adequately describe frailty.
Keywords: Acylcarnitines; Atrial fibrillation; Frailty; Inflammation; Older patients; Physical performance.
© 2024 The Author(s).
Conflict of interest statement
The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Figures


References
-
- Savelieva I., Fumagalli S., Kenny R.A., Anker S., Benetos A., Boriani G., et al. EHRA expert consensus document on the management of arrhythmias in frailty syndrome, endorsed by the Heart Rhythm Society (HRS), Asia Pacific Heart Rhythm Society (APHRS), Latin America Heart Rhythm Society (LAHRS), and Cardiac Arrhythmia Society of Southern Africa (CASSA). Europace: European pacing, arrhythmias, and cardiac electrophysiology. Journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology. 2023;25:1249–1276. doi: 10.1093/europace/euac123. - DOI - PMC - PubMed
-
- Fumagalli S., Potpara T.S., Bjerregaard Larsen T., Haugaa K.H., Dobreanu D., Proclemer A., et al. Frailty syndrome: an emerging clinical problem in the everyday management of clinical arrhythmias. The results of the European heart rhythm association survey. Europace: European pacing, arrhythmias, and cardiac electrophysiology. Journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology. 2017;19:1896–1902. doi: 10.1093/europace/eux288. - DOI - PubMed
-
- Fried L.P., Tangen C.M., Walston J., Newman A.B., Hirsch C., Gottdiener J., et al. Frailty in older adults: evidence for a phenotype. J. Gerontol A Biol. Sci. Med. Sci. 2001;56:M146–M156. - PubMed
LinkOut - more resources
Full Text Sources